StockNews.com Initiates Coverage on Mannatech (NASDAQ:MTEX)

Research analysts at StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEX) in a note issued to investors on Tuesday. The firm set a “buy” rating on the stock.

Mannatech Trading Down 6.2 %

Shares of MTEX opened at $7.88 on Tuesday. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.25 and a quick ratio of 0.74. The firm has a 50 day simple moving average of $7.83 and a 200-day simple moving average of $7.56. The stock has a market cap of $14.81 million, a price-to-earnings ratio of -9.73 and a beta of 1.17. Mannatech has a 1-year low of $6.75 and a 1-year high of $10.51.

Mannatech (NASDAQ:MTEX) last issued its quarterly earnings results on Tuesday, November 12th. The company reported ($0.17) EPS for the quarter. Mannatech had a negative return on equity of 15.62% and a negative net margin of 1.26%. The firm had revenue of $31.73 million for the quarter.

Insider Activity at Mannatech

In other news, Director Larry A. Jobe sold 16,288 shares of the business’s stock in a transaction dated Monday, September 9th. The stock was sold at an average price of $7.75, for a total transaction of $126,232.00. Following the completion of the sale, the director now owns 54,721 shares in the company, valued at approximately $424,087.75. The trade was a 22.94 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 41.50% of the stock is owned by insiders.

About Mannatech

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.